Purchase Order 75N91024P00108
Award Date 12/29/23
Potential Completion Date 12/28/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on November 20, 2019, with a ceiling value of $10,019.11 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers. Place of performance is Bethesda, MD. The order was firm fixed price with an ultimate completion date of December 20, 2019. No set-aside was used.</p>
- <p>The National Cancer Institute issued a $38,374.56 delivery order to Roche Diagnostics Corporation on February 27, 2020, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.</p> <p>Place of performance is Bethesda, MD 20892. The order was firm fixed price with an ultimate completion date of March 28, 2020. No set-aside was used.</p>
- <p>The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on October 24, 2017, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers, with a ceiling value of $17,786.27.</p> <p>Place of performance is Bethesda, MD 20892. The order carries a firm fixed price and an ultimate completion date of October 30, 2017. No set-aside was used.</p>
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a delivery order contract valued at $38,732 to Roche Diagnostics Corporation. The firm fixed price contract is for reagents and consumables to support Ventana Medical Systems Benchmark Ultra immunostainers. Performance will take place in Castleton, Indiana through November 2023. This delivery order was issued against an existing...
- Roche Diagnostics Corporation has been awarded a $25,082.18 firm fixed price delivery order for reagents and consumables in support of Ventana Medical Systems Benchmark Ultra immunostainers. The contract has no set-aside designation and was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute, located in Bethesda, Maryland. The reagents and consumables will support immunostaining activities at the National Cancer Institute's...
- <p>The National Cancer Institute issued a $24,823.86 delivery order to Roche Diagnostics Corporation on May 29, 2018, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.</p> <p>Place of performance is Castleton, IN. The order has a firm fixed price structure and an ultimate completion date of June 29, 2018. No set-aside was applied.</p>
- This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Roche Diagnostics Corporation for a service agreement to provide Ventana Benchmark Ultra Immunostainers. The contract has a ceiling value of $15,649.32 and a period of performance ending on March 24, 2026. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated...
- The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on December 4, 2018, with a ceiling value of $49,958.72 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers. Place of performance is Castleton, IN 46256. The order was issued on a firm fixed-price basis with an ultimate completion date of January 15, 2019. The delivery order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH OALM...
- <p>The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on September 4, 2018, with a ceiling value of $17,130.54 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.</p> <p>Place of performance is Castleton, IN. The order is firm fixed price with an ultimate completion date of October 31, 2018. No set-aside was used.</p>
- <p>The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on June 25, 2019, with a ceiling value of $11,248.12 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.</p> <p>Place of performance is Castleton, IN. The order is priced on a firm fixed-price basis with an ultimate completion date of July 24, 2019. No set-aside was used.</p>